medRxiv PreprintsInternational12 November 2026
Antibiotic receipt by respiratory symptom group and source of care among children under five in Bangladesh: repeated cross-sectional analyses of national surveys, 2019 and 2025
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Antibiotic use for childhood respiratory illness is common in low-income and middle-income countries, but national surveys rarely separate symptom groups or care pathways. We estimated antibiotic receipt among children under five in Bangladesh by reported respiratory symptom group, source of care and household wealth. Methods: We analysed the 2019 and 2025 Bangladesh Multiple Indicator Cluster Surveys. We included 4,010 children with cough and difficult breathing in the previous two weeks (3,990 in regression models). We compared breathing difficulty from the chest (suspected pneum
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Silent Drift and Site-level Variance in Clinical AI: Real-world performance and subgroup analysis for post-market monitoring of an FDA-cleared artificial intelligence (AI) triage tool for high-risk use case of pulmonary embolism12 November 2026
- Determinants of mpox vaccine acceptance among peri-urban residents in Sekondi-Takoradi, Western Region of Ghana: A community-based cross-sectional study12 November 2026
- Mapping disordered eating symptoms in the ABCD Study through the Eating Disorder Symptom Index12 November 2026
- Influenza Vaccination and Disease Severity Among Older Adults Hospitalized with Influenza in France: A Nationwide Cohort Study, 2016-202412 November 2026
- Associations of drinking water per- and polyfluoroalkyl substances with cause-specific mortality in men with prostate cancer12 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.